Legend Biotech is a multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies with the ultimate goal of changing the way life-threatening diseases are treated.
View all
NeoGenomics
Post IPO Equity • Fort Myers, United States
Ultragenyx Pharmaceutical
Post IPO Equity • Novato, United States
Sema4
Post IPO Equity • Stamford, United States
Aimmune Therapeutics
Post IPO Equity • Brisbane, United States
Atara Biotherapeutics
Post IPO Equity • South San Francisco, United States
Biohaven Pharmaceuticals
Post IPO Equity • New Haven, United States
Sage Therapeutics
Post IPO Equity • Cambridge, United States
Sarepta Therapeutics
Post IPO Equity • Cambridge, United States
Insmed
Post IPO Equity • Bridgewater, United States
Veracyte
Post IPO Equity • South San Francisco, United States
Standard BioTools
Post IPO Equity • South San Francisco, United States
NanoString
Post IPO Equity • Seattle, United States